Furthermore, data from The Cancer Genome Atlas indicated that higher CDKN2B‐AS1 levels in PCa tissues were correlated with larger tumour sizes (T3 + T4), more lymph node metastasis (N1), higher Gleason scores and shorter progression‐free survival. Here, CDKN2B is linked to posterior cortical atrophy.